Active Ingredient(s):Trilaciclib Dihydrochloride FDA Approved: * February 12, 2021 Pharm Company: *G1 THERAP Category:Cancer
Trilaciclib, sold under the brand name Cosela, is a medication used to reduce the frequency of chemotherapy-induced bone marrow suppression.
The most common side effects include fatigue; low levels of calcium, potassium and phosphate; increased levels of an enzyme called aspartate aminotransferase; headache; and infection in the lungs (pneumonia).
Trilaciclib may help protect bone marrow cells from ...
* May have multiple approval dates, manufacturers, or labelers.
Cosela 300 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution